Recording Now Available: “Next Steps for Obtaining Novel Endpoint Reliability & Acceptance” Webinar
A recording of CTTI’s public webinar on “Next Steps for Obtaining Novel Endpoint Reliability & Acceptance” is now available.
During the webinar, presenters Lindsay Kehoe (CTTI) and Alicia Staley (Medidata) discussed CTTI’s current work to obtain reliability and acceptance of meaningful, digitally derived novel endpoints – a project that builds on CTTI’s existing novel endpoint development recommendations and resources from 2017. They also provided:
- Highlights from a recent Expert Meeting of leaders and stakeholders from across the clinical trials ecosystem
- Insights from in-depth interviews with sponsors
- A preview of the forthcoming set of CTTI novel endpoint recommendations and resources
This webinar built on recent webinars by DiMe, which focused on the best resources currently available for using digitally derived endpoints, and TransCelerate, which demonstrated key considerations and challenges for developing novel digital endpoints through a hypothetical case study.
“As the novel endpoints space continues to evolve, CTTI, DiMe, and TransCelerate are committed to working together to help stakeholders across the clinical trials enterprise evolve with it,” said Kehoe. “By encouraging greater collaboration and innovation among technology companies, academic investigators, patients, regulators, and trial sponsors and sites, we can accelerate progress to the benefit of everyone involved.”
For more on CTTI’s work around Novel Endpoints, please visit CTTI’s website.